Dana Voight, MD
Payments from drug & device makers
Across 48 payments — averaging $101.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Biotissue Holdings Inc.$1K
- Davol Inc.$513
- Braintree Laboratories, Inc.$27
- Daiichi Sankyo Inc.$22
- Boston Scientific$21
- plus $48 from 3 others
What the payments were for
- Travel & lodging$71015%
- Food & beverage$1,74436%
- Education$2,40449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $3,046 |
| Biotissue Holdings Inc. | 16 | $1,180 |
| Davol Inc. | 4 | $513 |
| Braintree Laboratories, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,585
- DAVINCI XI$1,000
- PHASIX$457
- NEOX$298
- CLARIX$298
How this compares
$4,858 in reported general payments places this provider in the 65th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 19 | $9,683 |
| Mesalamine DrMesalamine | 17 | $4,223 |
| CholestyramineCholestyramine (With Sugar) | 38 | $4,159 |
| Sucralfate | 78 | $4,020 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 203 | $3,728 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 102 | $2,523 |
| Famotidine | 223 | $2,468 |
| Misoprostol | 33 | $2,194 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 126 | $1,868 |
| Dicyclomine Hcl | 92 | $1,481 |
| Pantoprazole Sodium | 102 | $1,183 |
| Omeprazole | 88 | $1,168 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $974 |
| Oxycodone Hcl | 36 | $570 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 27 | $513 |
Paid to pharmacies, not to this prescriber.
Other surgery in Rolla
- Tiffany OsbornSaint Louis$493K
- Jeffrey BlatnikSaint Louis$422K
- Varun PuriSaint Louis$346K
- Victor VidalsKansas City$327K
- James ScottSaint Louis$307K
- Andrew WheelerColumbia$298K
- Omar GuerraSaint Louis$249K
- Michael AwadSaint Louis$248K
- Carl FreemanSaint Louis$233K
- John TannColumbia$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.